Bindu Manyam Rusia MD (@manyamrusiamd) 's Twitter Profile
Bindu Manyam Rusia MD

@manyamrusiamd

Radiation Oncologist, Allegheny Health Network Cancer Institute.

ID: 778221189856686081

calendar_today20-09-2016 13:16:05

132 Tweet

575 Takipçi

126 Takip Edilen

Nikhil G. Thaker, MD (@ngthaker_xrt) 's Twitter Profile Photo

Interested in CMS’ proposed RO Model payment methodology? Honored to have the opportunity to work with my McKesson colleagues on a brief Journal of Oncology Practice blog article summarizing policy implications to practices and providing a few solutions. jopblog.org/blog/2019/12/1…

Fahima Dossa, MD PhD (@fdossa) 's Twitter Profile Photo

Can morbidity of surgery for rectal Ca be avoided? GRECCAR2 long-term results: no diff in 5yr OS/DFS after LE vs TME in pts w/good response to nCRT thelancet.com/journals/langa… But what do these results mean in the W&W era? Our editorial: thelancet.com/journals/langa… #colorectalsurgery

Can morbidity of surgery for rectal Ca be avoided? 

GRECCAR2 long-term results: no diff in 5yr OS/DFS after LE vs TME in pts w/good response to nCRT 
thelancet.com/journals/langa…

But what do these results mean in the W&W era? Our editorial: thelancet.com/journals/langa…
#colorectalsurgery
ASTRO Chair Jeff Michalski (@astro_chair) 's Twitter Profile Photo

JUST RELEASED: ASTRO #COVID19 Clinic Guidelines. A survey of flagship academic & community #cancer programs & their institutional recommendations. View guidelines here: ow.ly/X7pU50yOZ7N

Kevin Stephans MD (@mdstephans) 's Twitter Profile Photo

(1/5) The COVID era is a perfect time to adopt single fraction lung SBRT.  This is supported by two randomized trials suggesting comparable outcome for 30-34 Gy in 1 fraction for medically inoperable peripheral stage I NSCLC randomized w 48 Gy/4 fx, and 54-60 Gy/3 fx.  #radonc.

Mudit Chowdhary, MD (@drchowdharymd) 's Twitter Profile Photo

🔥H&N studies #ASCO20 T1-2N0 oral cavity & OPX -SLN Bx = Neck disssection, w/⬇️morbidity ECOG E3311 -p16+ OPX s/p TORS ➡️RT -50 Gy = 60 Gy, w/⬇️toxicity JCOG 1008 -Cisplatin weekly = bolus, w/⬇️toxicity ⬆️swallowing with dysphagia optimized RT #radonc #hncsm #oncoalert

🔥H&N studies #ASCO20 

T1-2N0 oral cavity & OPX 
-SLN Bx = Neck disssection, w/⬇️morbidity

ECOG E3311
-p16+ OPX s/p TORS ➡️RT
-50 Gy = 60 Gy, w/⬇️toxicity

JCOG 1008
-Cisplatin weekly = bolus, w/⬇️toxicity

⬆️swallowing with dysphagia optimized RT

#radonc #hncsm #oncoalert
Chirag Shah (@cshahmd) 's Twitter Profile Photo

In patients with low-risk early stage breast cancer, consideration for partial breast irradiation alone as compared to endocrine therapy alone for de-intensification: link.springer.com/article/10.100… Great to collaborate with Matthew Ward Nikhil G. Thaker, MD Atif J Khan Zahraa Al-Hilli #bcsm

Claire Paterson 💙 (@claire_paters0n) 's Twitter Profile Photo

Our data on involved neck only RT Vs TMI for HNSCC UKP, p16 + & -. All patients underwent PET-CT. Less acute & late tox with neck only RT, no primaries emerged, disease control not compromised #hncsm #radonc maureenct0957 @carolynnscrim onlinelibrary.wiley.com/doi/abs/10.111…

Shauna Campbell, DO (@shaunaradonc) 's Twitter Profile Photo

Great session (EDU21) on hypofx RT for #HNCSM @ #ASTRO20. Shlomo Koyfman from #CleClinicCancer shares great advice & his thought process on balancing definitive treatment in locally advanced cases that can't tolerate SOC. Trainee goal➡️develop this clinical mind Cleveland Clinic MD

Great session (EDU21) on hypofx RT for #HNCSM @ #ASTRO20. <a href="/ShlomoKoyfmanMD/">Shlomo Koyfman</a> from #CleClinicCancer shares great advice &amp; his thought process on balancing definitive treatment in locally advanced cases that can't tolerate SOC. Trainee goal➡️develop this clinical mind <a href="/CleClinicMD/">Cleveland Clinic MD</a>
Chris Estes (@estesradonc) 's Twitter Profile Photo

Great review of osteoradionecrosis in H&N! (new go-to source) bit.ly/38QLBAH Risk factors: mandibular surgery, smoking/alcohol. Less ORN with IMRT. Some report pre-RT extractions as a risk factor but possibility of a confounder here 1/3

Pierre Blanchard, MD (@pblanchardmd) 's Twitter Profile Photo

Last update of the MACH-NC individual patient data meta-analysis of chemo for locally advanced HN Cancers is out here: bit.ly/31f2d0L Massive collaborative effort, with lots of details (75p supplementary appendix for those interested...). #radonc #hncsm THREAD below

Last update of the MACH-NC individual patient data meta-analysis of chemo for locally advanced HN Cancers is out here: bit.ly/31f2d0L

Massive collaborative effort, with lots of details (75p supplementary appendix for those interested...).

#radonc #hncsm

THREAD below
Matthias Guckenberger (@mat_guc) 's Twitter Profile Photo

Full publication HILUS trial, SBRT for ultra-central lung tumors SBRT 8x7Gy to PTV encompassing 67% isodose 👉 36 mo LC 83% 👉 22/65 pts grade 3-5 tox 👉 10 Tx related death, all pulmonary 👉 almost all G5 in tumors ≤1cm from main bronchi/trachea #radoc jto.org/article/S1556-…

Head and Neck Cancer International Group (@h_n_c_i_g) 's Twitter Profile Photo

#ASCO2021 Robert Ferris, MD, PhD presents ECOG 3311 update - 3y PFS 94.9% (TOS+50Gy) vs 93.5% (TOS+60Gy). Potential QoL/tox benefits with 50Gy. Do we need more evidence to recommend 50Gy following TOS for close margins (<3mm), 2-3 LN, ≤1mm ENE and PNI/LVI? #hncsm

Chirag Shah (@cshahmd) 's Twitter Profile Photo

Management of the axilla is one of the most challenging and rapidly evolving areas of breast cancer RT(#bcsm). Wanted to present common scenarios and management, lots of different and correct ways to proceed Atif J Khan Wendy Woodward MDPhD Reshma Jagsi Jonathan Strauss Rahul Tendulkar, MD #1

Avraham Z. Cooper, MD 🩺 (@avrahamcoopermd) 's Twitter Profile Photo

1/🧵 Ever wonder why corticosteroids like dexamethasone treat cerebral edema related to brain tumors? I assumed the answer involved "anti-inflammatory effects", but there's much more going on. #medtwitter #tweetorial

1/🧵
Ever wonder why corticosteroids like dexamethasone treat cerebral edema related to brain tumors?

I assumed the answer involved "anti-inflammatory effects", but there's much more going on.

#medtwitter #tweetorial
Sushil (@sushilberiwal) 's Twitter Profile Photo

First program of its type In western Pennsylvania focusing on survivorship and objective improvement in health metrics in cancer patients ⁦Colin Champ, M.D.⁩ ⁦AHN⁩ ⁦Bindu Manyam Rusia MD⁩ onclive.com/view/ahn-cance…